Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaim Putterman

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Clinical Immunology (Orlando, Fla.)|November 19, 2017
Lupus Nephritis: Persistent Challenges, New ApproachesChaim Putterman
Autoimmunity Reviews|March 9, 2004
New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosusChaim Putterman
American Journal of Orthopedics (Belle Mead, N.J.)|September 25, 2007
The new era in the treatment of rheumatoid arthritisChaim Putterman
American Journal of Orthopedics (Belle Mead, N.J.)|May 12, 2007
Introduction: new treatment paradigms in rheumatoid arthritisChaim Putterman
The Journal of Rheumatology|October 3, 2013
Commentary on "The risky business of studying prognosis"Anna Broder, Chaim Putterman
Nature Reviews. Nephrology|April 1, 2015
Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritisChandra Mohan, Chaim Putterman
Journal of Biomedicine & Biotechnology|February 19, 2011
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosusMaria Gulinello, Chaim Putterman
Journal of Autoimmunity|June 15, 2020
Are lupus animal models useful for understanding and developing new therapies for human SLE?Erica Moore, Chaim Putterman
The Journal of Rheumatology|August 4, 2012
Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosusAnna Broder, Chaim Putterman
Arthritis Research & Therapy|December 19, 2009
The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritisPierre Youinou, Chaim Putterman
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Clinical Immunology (Orlando, Fla.)|November 19, 2017
Lupus Nephritis: Persistent Challenges, New ApproachesChaim Putterman
Autoimmunity Reviews|March 9, 2004
New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosusChaim Putterman
American Journal of Orthopedics (Belle Mead, N.J.)|September 25, 2007
The new era in the treatment of rheumatoid arthritisChaim Putterman
American Journal of Orthopedics (Belle Mead, N.J.)|May 12, 2007
Introduction: new treatment paradigms in rheumatoid arthritisChaim Putterman
The Journal of Rheumatology|October 3, 2013
Commentary on "The risky business of studying prognosis"Anna Broder, Chaim Putterman
Nature Reviews. Nephrology|April 1, 2015
Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritisChandra Mohan, Chaim Putterman
Journal of Biomedicine & Biotechnology|February 19, 2011
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosusMaria Gulinello, Chaim Putterman
Journal of Autoimmunity|June 15, 2020
Are lupus animal models useful for understanding and developing new therapies for human SLE?Erica Moore, Chaim Putterman
The Journal of Rheumatology|August 4, 2012
Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosusAnna Broder, Chaim Putterman
Arthritis Research & Therapy|December 19, 2009
The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritisPierre Youinou, Chaim Putterman
Pageof 21